Sudeep Pharma Share Price

Sudeep Pharma Limited was incorporated as Sudeep Pharma Private Limited as a private limited company dated December 21 1989 issued by the Registrar of Companies Ahmedabad. Thereafter Company was converted into a public limited company and the name of the Company was changed to Sudeep Pharma Limited pursuant to fresh certificate of incorporation dated April 5 1995 issued by the Assistant Registrar of Companies Gujarat at Dadra Nagar Haveli. Company was subsequently converted back to a private limited company vide a fresh certificate of incorporation dated October 1 2014 issued by the Assistant Registrar of Companies Gujarat at Ahmedabad and the name of Company was accordingly changed from Sudeep Pharma Limited to Sudeep Pharma Private Limited. Further Company was converted into a public limited company and consequently the name of Company was changed to Sudeep Pharma Limited.The Company is one of the pioneers in India to introduce a product range of liposomal ingredients for nutrient absorption and stability. The Company is a technology led manufacturer of excipients and specialty ingredients for the pharmaceutical food and nutrition industries. It operate three manufacturing facilities in Vadodara Gujarat with an annual installed capacity of 65 579 MT. Since inception in 1989 Company has expanded business operations from production of excipients to a wide variety of over 100 products in the pharmaceutical food and nutrition industries. Business is primarily structured into two verticals: Pharmaceutical food and nutrition and Specialty ingredients. The Company focus on providing refined mineralbased single ingredients essential to the pharmaceutical food and nutrition industries.. Many of these minerals act as excipients supporting the efficacy and stability of pharmaceutical formulations. Specialty ingredients entails production of customized ingredients to improve functionality stability and bioavailability across food and nutraceuticalapplications. These specialty ingredients play a key role in enhancing nutritional profiles texture and flavour across applications such as fortified dairy beverages and bakery products as well as dietary supplements. Company is planning to launch the initial public offer by raising funds of Rs 95 Crore equity shares through fresh issue and by issuing 10076492equity shares having the face value of Rs 1/ each via offer for sale..

Revenue: ₹162.67Cr as on September 2025 (Q2 FY26)
Net Profit: ₹46.78Cr as on September 2025 (Q2 FY26)
Listing date: 28 Nov, 2025